CSCC_ASC Therapy in Patients With Severe Heart Failure
NCT02387723 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2016-02-02
Summary
The present aim is to perform at small clinical safety trial in heart failure patients with allogeneic adipose tissue derived mesenchymal stem cells.
Conditions
Interventions
- BIOLOGICAL
-
Allogeneic adipose derived stem cells (CSCC_ASC)
Culture expanded allogeneic adipose derive stem cells (CSCC\_ASC)
Sponsors & Collaborators
-
JKastrup
lead OTHER
Principal Investigators
-
Jens Kastrup, Professor MD · Rigshospitalet, Denmark
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
Countries
- Denmark
Study Locations
More Related Trials
-
Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia
NCT00260338 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure
NCT01502501 ·Status: WITHDRAWN ·Phase: NA
-
Stem Cell Therapy in Chronic Ischemic Heart Failure
NCT00235417 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)
NCT00203203 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Mesenchymal Stromal Cell Therapy in Heart Failure
NCT00644410 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure
NCT01502514 ·Status: WITHDRAWN ·Phase: PHASE1
-
Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement
NCT00869024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.
NCT02503280 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
NCT01557543 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Circulating Levels of Adult Stem Cells in the Peripheral Blood of Patients With Acute Decompensated Heart Failure and Following Stabilization, in Comparison With Healthy Volunteers
NCT01027403 ·Status: COMPLETED
-
Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction
NCT01974128 ·Status: WITHDRAWN ·Phase: NA
-
Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM
NCT03572660 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction
NCT00893360 ·Status: COMPLETED ·Phase: PHASE1
-
Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization
NCT04005989 ·Status: WITHDRAWN ·Phase: PHASE3
-
Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.
NCT02033278 ·Status: TERMINATED ·Phase: PHASE2
-
Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure
NCT02501811 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure
NCT00747708 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.
NCT06705023 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)
NCT04939077 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure
NCT00721045 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells
NCT05925608 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)
NCT01449032 ·Status: COMPLETED ·Phase: PHASE2
-
Mesenchymal Stem Cells and Myocardial Ischemia
NCT01076920 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure
NCT02032004 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Atrial Appendage Derived Cells in the Treatment of Heart Failure
NCT02672163 ·Status: COMPLETED ·Phase: NA